Page last updated: 2024-12-07

9-o-acetyl-n-acetylneuraminic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123962
CHEBI ID21500
SCHEMBL ID420656
MeSH IDM0085335

Synonyms (21)

Synonym
5-acetamido-9-o-acetyl-3,5-dideoxy-d-glycero-beta-d-galacto-non-2-ulopyranosonic acid
n-acetyl-9-o-acetylneuraminic acid
9-o-acetylsialic acid
CHEBI:21500
9-o-acetyl-n-acetylneuraminic acid
55717-54-9
9-anana
(2s,4s,5r,6r)-5-acetamido-6-[(1r,2r)-3-acetyloxy-1,2-dihydroxypropyl]-2,4-dihydroxyoxane-2-carboxylic acid
d-glycero-d-galacto-2-nonulosonic acid, 5-(acetylamino)-3,5-dideoxy-, 9-acetate
SCHEMBL420656
5-n-acetyl-9-o-acetyl neuraminic acid
W-203102
(2s,4s,5r,6r)-6-[(1r,2r)-3-(acetyloxy)-1,2-dihydroxypropyl]-5-acetamido-2,4-dihydroxyoxane-2-carboxylic acid
n,9-o-diacetylneuraminic acid
9-o-acetyl-n-acetylneuraminate
Q27109402
(2s,4s,5r,6r)-5-acetamido-6-[(1r,2r)-3-acetyloxy-1,2-dihydroxypropyl]-2,4-dihydroxy-2-oxanecarboxylic acid
9-o-acetyl-3,5-dideoxy-5-[(1-hydroxyethylidene)amino]non-2-ulopyranosonic acid
DTXSID40971088
81228-99-1
(2s,4s,5r,6r)-5-acetamido-6-((1r,2r)-3-acetoxy-1,2-dihydroxypropyl)-2,4-dihydroxytetrahydro-2h-pyran-2-carboxylic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
N-acetyl-O-acetylneuraminic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (18.46)18.7374
1990's34 (52.31)18.2507
2000's11 (16.92)29.6817
2010's4 (6.15)24.3611
2020's4 (6.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.43 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index13.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (4.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (95.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]